Document is current
Any future updates will be listed below
-
Authors
Sánchez-Sáez, Francisco https://orcid.org/0000-0002-3011-9884
Sanfélix-Gimeno, Gabriel https://orcid.org/0000-0001-7098-4576
Hurtado, Isabel https://orcid.org/0000-0002-8475-8112
García-Sempere, Aníbal https://orcid.org/0000-0002-4313-3976
Garcés-Sánchez, María https://orcid.org/0000-0002-5838-9333
Llopis-Cardona, Fran https://orcid.org/0000-0002-9045-1651
Peiró, Salvador https://orcid.org/0000-0002-3902-569X
Rodríguez-Bernal, Clara L. https://orcid.org/0000-0003-2617-8635
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (RD21/0016/0006, co-funded by European Union-ERDF)
Ministerio de Universidades (PID2021-128519OB-100)
- License Information
-
More Information
Article History
Received: 4 December 2024
Accepted: 6 June 2025
First Online: 23 June 2025
Declarations
:
: The project was developed in accordance with the Declaration of Helsinki, the International Guidelines for Ethical Review of Epidemiological Studies, European and Spanish regulation on biomedical research, and European regulation (General Data Protection Regulation 2016/679; GDPR-2016) and Spanish (Organic Law 3/2018, of December 5, on the Protection of Personal Data and guarantee of digital rights; LOPDP-2018) on protection of personal data. The project uses pseudo-anonymized data transferred after the corresponding authorization by the Regional Health Authority (Conselleria de Sanidad Universal y Salud Pública) of the Valencia region that is be responsible for the anonymization and will retain the necessary information for a possible reidentification in the cases provided by law. The project was submitted for approval by the Drug Research Ethics Committee (CEIm) of the University Hospital Clinic of Valencia.
: Informed consent need was waved by the ethics committee given the nature of the source of data.
: The authors have no relevant financial or non-financial interests to disclose.
